Mike Clark
27Patents
12h-index
13Co-inventors
78Inventor score
Filing activity: Nov 4, 1993 → Feb 17, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6183738A | Modified arginine deiminase | Emerging Cross-Sectional Technologies | 102 | Expired |
| US6913915B2 | PEG-modified uricase | Human Necessities | 68 | Expired |
| US10630642B2 | Methods for internet communication security | Electricity | 33 | Active |
| US5686110A | Water soluble complex of an alkyl or olefinic end capped polyalkylene oxide and a water insoluble substance | Human Necessities | 30 | Expired |
| US11558423B2 | Methods for zero trust security with high quality of service | Electricity | 28 | Active |
| US10361859B2 | Methods for internet communication security | Electricity | 24 | Active |
| US7204980B2 | Methods for inhibiting viral replication in vivo | Emerging Cross-Sectional Technologies | 23 | Expired |
| US6645739B2 | Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same | Chemistry; Metallurgy | 18 | Expired |
| US6635462B1 | Mutated form of arginine deiminase | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6737259B1 | Modified arginine deiminase | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6013283A | Alkyl or olefinic endcapped polyalkylene oxide solubilizer | Human Necessities | 14 | Expired |
| US10367811B2 | Methods for internet communication security | Electricity | 14 | Active |
| US5527775A | Reduction of mammalian neoplasms with phospholipase A2 activating substances | Chemistry; Metallurgy | 10 | Expired |
| US7323167B2 | Method of treatment with modified arginine deiminase | Emerging Cross-Sectional Technologies | 10 | Expired |
| US11245529B2 | Methods for internet communication security | Electricity | 8 | Active |
| US10374803B2 | Methods for internet communication security | Electricity | 8 | Active |
| US5728560A | Method of treating CD4+ T cell lymphopenia in immuno-compromised patients | Chemistry; Metallurgy | 8 | Expired |
| US11463256B2 | Methods for internet communication security | Electricity | 6 | Active |
| US10375019B2 | Methods for internet communication security | Electricity | 5 | Active |
| US10397186B2 | Methods for internet communication security | Electricity | 3 | Active |
| US5367063A | Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis | Chemistry; Metallurgy | 2 | Expired |
| US5786154A | Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis | Chemistry; Metallurgy | 1 | Expired |
| US11930007B2 | Methods for internet communication security | Electricity | 0 | Active |
| US10965646B2 | Methods for internet communication security | Electricity | 0 | Active |
| US7785579B2 | Modified tumor necrosis factor | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.